Non Hodgkin Lymphoma Clinical Trial

Long-Term Follow-up Study

Summary

This is a non-interventional, long-term safety study of allogeneic CAR-T cell therapy in patients with hematologic malignancies. Its purpose of is to collect long-term observational data to identify and understand potential late side effects in patients who have received CAR-T cell therapies.

View Full Description

Full Description

This is a non-interventional, long-term safety study of allogeneic CAR-T cell therapy in patients who have participated in a prior Caribou-sponsored clinical study, in a special access program, or in another study such as an IIT. The purpose of this 15-year research study is to collect long-term observational data to identify and understand potential late side effects in these patients.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Written informed consent obtained prior to study-specific activities/enrollment
Received a Caribou allogeneic CAR-T therapy and completed or discontinued from a Caribou-sponsored study evaluating an allogeneic CAR-T therapy or was administered an allogeneic CAR-T therapy under a special access program or as part of an IIT

Exclusion Criteria:

None

Study is for people with:

Non Hodgkin Lymphoma

Estimated Enrollment:

150

Study ID:

NCT05332054

Recruitment Status:

Enrolling by invitation

Sponsor:

Caribou Biosciences, Inc.

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 15 Locations for this study

See Locations Near You

Honor Health Research Institute
Scottsdale Arizona, 85258, United States
University of California Irvine
Irvine California, 92868, United States
University of California San Diego
La Jolla California, 92093, United States
AdventHealth Medical Group Blood & Marrow Transplant at Orlando
Orlando Florida, 32804, United States
Blood & Marrow Transplant Group of Georgia
Atlanta Georgia, 30342, United States
Augusta University/Georgia Cancer Center
Augusta Georgia, 30912, United States
University of Iowa Hospitals & Clinics
Iowa City Iowa, 52242, United States
Norton Cancer Institute
Louisville Kentucky, 40207, United States
Atlantic Health System Cancer Care
Morristown New Jersey, 07960, United States
Icahn School of Medicine at Mt. Sinai
New York New York, 10029, United States
Oncology Hematology Care
Cincinnati Ohio, 45242, United States
Sarah Cannon Research Institute - TriStar Health
Nashville Tennessee, 37203, United States
Baylor Research Institute
Dallas Texas, 75246, United States
MD Anderson Cancer Center
Houston Texas, 77030, United States
Huntsman Cancer Institute at the University of Utah
Salt Lake City Utah, 84112, United States

How clear is this clinincal trial information?

Study is for people with:

Non Hodgkin Lymphoma

Estimated Enrollment:

150

Study ID:

NCT05332054

Recruitment Status:

Enrolling by invitation

Sponsor:


Caribou Biosciences, Inc.

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.